companydata.dkJJ PHARMA CONSULT ApS: Financial statements 2020
CVR: 33257635
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -20,275 and a net result of DKK 1,010,038 compared with DKK -27,282 the year before. Equity amounted to DKK 2,697,013. The solvency ratio was 98.4%.
- Gross Profit
- -20,275 kr.
- Profit/Loss
- 1,010,038 kr.
- Equity
- 2,697,013 kr.
- Total Assets
- 2,741,012 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -20 t. | 1 mio. | 2.7 mio. | - |
| 2019 | - | -22 t. | -27 t. | 1.8 mio. | - |
| 2018 | - | -40 t. | -43 t. | 2 mio. | 0 |
| 2017 | - | -18 t. | 585 t. | 2.1 mio. | - |
| 2016 | - | -45 t. | 315 t. | 1.6 mio. | - |
How creditworthy is JJ PHARMA CONSULT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
JJ PHARMA CONSULT ApS has published its annual report for 2019. Gross profit came to DKK -22,331, and the net result was DKK -27,282.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity amounted to DKK 16,917,153.